J. McDougall - May 11, 2021 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role
Director
Signature
/s/ Sam Backenroth, as attorney-in-fact for Gerald McDougall
Stock symbol
NBSE
Transactions as of
May 11, 2021
Transactions value $
$0
Form type
4
Date filed
5/13/2021, 06:03 PM
Next filing
Sep 17, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBSE Employee stock option (right to buy) Award $0 +92.2K $0.00 92.2K May 11, 2021 Common stock 92.2K $4.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the total shares shall vest on the first anniversary of the grant date, and 1/36th of the remaining shares shall vest on a monthly basis thereafter.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.